Temasek Holdings Made Need More Aspirin on Disastrous Bayer Investment

Posted on 04/05/2019

German pharmaceutical giant Bayer AG has seen its stock halved since its highs in 2015, and relief is not on the horizon. Bayer’s fortunes took a turn for the worse after raising US$ 3.7 billion for its US$ 62.5 billion purchase of agricultural science group Monsanto. Bayer was able to do it by selling a […]